comparemela.com

Latest Breaking News On - Equinox science - Page 1 : comparemela.com

EyePoint reports Duravyu trial fail, raising questions

EyePoint reports Duravyu trial fail, raising questions
fiercepharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercepharma.com Daily Mail and Mail on Sunday newspapers.

China
Eyepoint-duravyu
Graig-suvannavejh
Alimera-sciences
Betta-pharmaceuticals
Eyepoint-pharmaceuticals
Diabetic-retinopathy-severity-scale
Equinox-science
China-approved-yutiq

EyePoint Pharmaceuticals Reports Third Quarter 2023 Financial Results and Highlights Recent Corporate Developments

– Positive masked safety data update for EYP-1901 in ongoing PAVIA and DAVIO 2 Phase 2 clinical trials as of October 1, 2023 with no drug related .

United-states
Massachusetts
Watertown
American
Amy-phillips
Jays-duker
Christina-tartaglia
Marcia-sellos-moura
Jay-duker
Program-leadership-on
Betta-pharmaceuticals
American-academy-of-ophthalmology

EyePoint Pharmaceuticals : EYPT Investor Presentation October 2023 -October 17, 2023 at 05:16 pm EDT

Investor Presentation October 2023 Forward-Looking Statements Various statements made in this presentation.

Exchange-commission
Betta-pharmaceuticals
Forward-looking-statements
Securities-litigation-reform-act
Ocumension-therapeutics
Equinox-science
Markets

EyePoint Pharmaceuticals, Inc.: EyePoint Pharmaceuticals Strengthens Board and Executive Leadership Team

EyePoint Pharmaceuticals, Inc.: EyePoint Pharmaceuticals Strengthens Board and Executive Leadership Team
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Massachusetts
United-states
Watertown
Jays-duker
Amy-phillips
Indiens-wirtschaft
Christina-tartaglia
Ihre-chancen
George-elston
Eyepoint-pharmaceuticals-nasdaq
Exchange-commission
Harvard-business-school

EyePoint Pharmaceuticals Strengthens Board and Executive Leadership Team - EyePoint Pharmaceuticals (NASDAQ:EYPT)

– Stuart Duty appointed to EyePoint's Board of Directors – – George Elston promoted to Executive Vice President – WATERTOWN, Mass., Oct. 16, 2023 (GLOBE NEWSWIRE) EyePoint Pharmaceuticals, Inc.

Massachusetts
United-states
Watertown
Christina-tartaglia
George-elston
Jays-duker
Amy-phillips
Eyepoint-pharmaceuticals-inc
Occidental-college
Guggenheim-securities
Betta-pharmaceuticals
Piper-jaffray

vimarsana © 2020. All Rights Reserved.